19-44908756-C-T

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM5PP2PP3_StrongPP5

The NM_000041.4(APOE):​c.460C>T​(p.Arg154Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,559,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R154L) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000058 ( 0 hom. )

Consequence

APOE
NM_000041.4 missense

Scores

7
9
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:1

Conservation

PhyloP100: 1.06

Publications

27 publications found
Variant links:
Genes affected
APOE (HGNC:613): (apolipoprotein E) The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. [provided by RefSeq, Jun 2016]
APOE Gene-Disease associations (from GenCC):
  • Alzheimer disease 2
    Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hyperlipoproteinemia type 3
    Inheritance: AD, AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • lipoprotein glomerulopathy
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Genomics England PanelApp
  • sea-blue histiocyte syndrome
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_000041.4
PM5
Other missense variant is known to change same aminoacid residue: Variant chr19-44908757-G-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 375636.Status of the report is criteria_provided_single_submitter, 1 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 16 curated pathogenic missense variants (we use a threshold of 10). The gene has 2 curated benign missense variants. Gene score misZ: 0.74028 (below the threshold of 3.09). Trascript score misZ: -1.1391 (below the threshold of 3.09). GenCC associations: The gene is linked to hyperlipoproteinemia type 3, sea-blue histiocyte syndrome, lipoprotein glomerulopathy, Alzheimer disease 2.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.978
PP5
Variant 19-44908756-C-T is Pathogenic according to our data. Variant chr19-44908756-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 3572888.We mark this variant Likely_pathogenic, oryginal submission is: [Conflicting_classifications_of_pathogenicity].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APOENM_000041.4 linkc.460C>T p.Arg154Cys missense_variant Exon 4 of 4 ENST00000252486.9 NP_000032.1 P02649A0A0S2Z3D5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APOEENST00000252486.9 linkc.460C>T p.Arg154Cys missense_variant Exon 4 of 4 1 NM_000041.4 ENSP00000252486.3 P02649
APOEENST00000425718.1 linkc.460C>T p.Arg154Cys missense_variant Exon 3 of 3 1 ENSP00000410423.1 E7ERP7
APOEENST00000434152.5 linkc.538C>T p.Arg180Cys missense_variant Exon 4 of 4 2 ENSP00000413653.2 H0Y7L5
APOEENST00000446996.5 linkc.460C>T p.Arg154Cys missense_variant Exon 4 of 4 2 ENSP00000413135.1 E9PEV4

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152130
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000883
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000898
AC:
14
AN:
155926
AF XY:
0.000141
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000989
Gnomad OTH exome
AF:
0.000228
GnomAD4 exome
AF:
0.0000575
AC:
81
AN:
1407496
Hom.:
0
Cov.:
33
AF XY:
0.0000661
AC XY:
46
AN XY:
695626
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32230
American (AMR)
AF:
0.00
AC:
0
AN:
36776
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25176
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36650
South Asian (SAS)
AF:
0.000162
AC:
13
AN:
80198
European-Finnish (FIN)
AF:
0.0000636
AC:
3
AN:
47196
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5132
European-Non Finnish (NFE)
AF:
0.0000571
AC:
62
AN:
1085812
Other (OTH)
AF:
0.0000514
AC:
3
AN:
58326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152242
Hom.:
0
Cov.:
32
AF XY:
0.0000403
AC XY:
3
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41570
American (AMR)
AF:
0.00
AC:
0
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000883
AC:
6
AN:
67972
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.0000359
AC:
4
Asia WGS
AF:
0.000289
AC:
1
AN:
3468

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Familial type 3 hyperlipoproteinemia Pathogenic:1Uncertain:1
May 16, 2023
Institute of Human Genetics, University of Leipzig Medical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Criteria applied: PM5,PP3,PS4_SUP -

Feb 19, 2024
3billion
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.009%). Predicted Consequence/Location: Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.71 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.80 (>=0.6, sensitivity 0.72 and precision 0.9)]. Same nucleotide change resulting in same amino acid change has been previously reported to be associated with APOE related disorder (PMID: 7907341 /3billion dataset).Different missense changes at the same codon (p.Arg154His, p.Arg154Leu, p.Arg154Ser) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000017850, VCV000375636 /PMID: 27353043, 3243553, 7706948). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -

Alzheimer disease 2 Pathogenic:1
Mar 09, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Pathogenic
0.32
D
BayesDel_noAF
Pathogenic
0.22
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.59
D;T;.;.
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.81
T;T;T;T
M_CAP
Pathogenic
0.46
D
MetaRNN
Pathogenic
0.98
D;D;D;D
MetaSVM
Uncertain
0.44
D
MutationAssessor
Uncertain
2.2
M;.;.;.
PhyloP100
1.1
PrimateAI
Uncertain
0.62
T
PROVEAN
Pathogenic
-6.2
D;D;.;D
REVEL
Pathogenic
0.71
Sift
Uncertain
0.0010
D;D;.;D
Sift4G
Pathogenic
0.0010
D;D;D;D
Polyphen
1.0
D;.;.;.
Vest4
0.88
MutPred
0.94
Loss of disorder (P = 0.0146);Loss of disorder (P = 0.0146);.;Loss of disorder (P = 0.0146);
MVP
0.94
MPC
1.9
ClinPred
0.66
D
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.69
gMVP
0.80
Mutation Taster
=17/83
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121918393; hg19: chr19-45412013; API